Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
Clinical trial NCT04707469 · COMPLETED
Trial details
- NCT number
- NCT04707469
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2023-03-07
- Enrollment
- 1606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.